RNA-binding proteins of the ZFP36 family are best known for inhibiting the expression of cytokines through binding to AU-rich elements in the 3′ untranslated region and promoting mRNA decay. Here we identified an indispensable role for ZFP36L1 as the regulator of a post-transcriptional hub that determined the identity of marginal-zone B cells by promoting their proper localization and survival. ZFP36L1 controlled a gene-expression program related to signaling, cell adhesion and locomotion; it achieved this in part by limiting expression of the transcription factors KLF2 and IRF8, which are known to enforce the follicular B cell phenotype. These mechanisms emphasize the importance of integrating transcriptional and post-transcriptional processes by RNA-binding proteins for maintaining cellular identity among closely related cell types.
Marginal-zone (MZ) B cells surround the follicles of the spleen and are continuously exposed to blood-borne antigens. This positioning of MZ B cells enables them to provide immunosurveillance and shuttle antigens to follicular dendritic cells 1, 2 . Their localization to the MZ and their trafficking to and from the B cell follicle also contributes to their survival [2] [3] [4] [5] . Upon encountering antigens, MZ B cells are poised to promote the activation of T cells by presenting antigen as well as differentiating into plasmablasts 6 . MZ B cells have higher expression of surface immunoglobulin M (IgM), the complement receptors CD35 and CD21 and the lipid-antigen-presenting molecule CD1d than do follicular (Fo) B cells. Together with their elevated expression of Tolllike receptors, these features facilitate rapid responses to blood-borne pathogens such as encapsulated bacteria 7, 8 . MZ B cells develop through an intermediary population of MZ precursor (MZP) cells that express C-type lectin CD93 (ref. 9 ). The selection of MZ B cells depends on signaling by membrane immunoglobulins and the receptors Notch2 and BAFF-R 7, 9 . MZ and Fo B cells can be distinguished on the basis of their gene-expression profiles 10 , and the differences in their transcriptomes contribute to the differential development, localization and function of these cells. Transcriptional regulators have been shown to have specific roles in MZ and Fo B cells. Notch2 is necessary for promotion of the MZ B cell fate 11, 12 . The transcription factor IRF4 and its paralog IRF8 limit the size of MZ B cell pool 13 , and IRF4 regulates the positioning of cells in the MZ. The transcription factor KLF2 enforces the Fo B cell phenotype. In its absence, the MZ B cell pool is expanded 14, 15 . In contrast, KLF3, which may antagonize KLF2, promotes the development of MZ B cells 16 . The genes encoding these factors are frequently mutated in splenic MZ lymphoma 17 , which suggests that they might also form part of a network that sustains the survival and localization of MZ B cells in pathological situations. Thus, the interrelationship among transcriptional regulation, signal transduction and cell positioning for the development and survival of MZ B cells needs to be further understood 17 .
The post-transcriptional control of RNA regulated by RNA-binding proteins (RBPs) and non-coding RNA complements transcriptional control by adding robustness to gene-regulatory networks 18 . Deletion of the endoribonuclease Dicer 19 or the microRNA miR-142 (ref. 20) leads to an increased proportion of B cells with an MZ phenotype, which suggests that microRNAs suppress the formation or survival of MZ B cells. Retroviral expression of the RBP lin28b in hematopoietic stem cells promotes the development of MZ B cells 21, 22 , but roles have not been found for other RBPs in MZ B cells.
The ZFP36 family of RBPs are characterized by tandem CCCH-type zinc fingers, which bind RNA. By interacting with AU-rich elements in the 3′ untranslated region (UTR) of mRNA, these RBPs promote RNA decay 23 . ZFP36 has been best characterized as a suppressor of cytokine production in innate immune cells; its relatives ZFP36L1 and ZFP36L2 serve redundant roles during the development of T lymphocytes and B lymphocytes 24, 25 . The function of the ZFP36 family during the development and maintenance of mature B lymphocytes has not been studied.
Here we found an indispensable role for ZFP36L1 in the maintenance of MZ B cells. Through analysis of the transcriptomes of primary mouse B cells and the identification of ZFP36L1 targets in B cells by individual-nucleotide-resolution cross-linking and immunoprecipitation (iCLIP), we identified the direct and indirect targets of ZFP36L1 in B cells and determined a network of factors under the 6 8 4 VOLUME 18 NUMBER 6 JUNE 2017 nature immunology A r t i c l e s control of ZFP36L1 that promote the localization and survival of MZ B cells. Our study demonstrates that a single RBP can determine the cellular identity and, ultimately, the survival of MZ B cells.
RESULTS

MZ B cells specifically require ZFP36L1
To identify the roles of the ZFP36 family during lymphocyte development, we first generated Zfp36 fl/fl CD2-iCre + mice, in which loxPflanked Zfp36 alleles (Zfp36 fl/fl ) are deleted by a transgene encoding 'codon-improved' Cre recombinase (iCre) expressed from the promoter of the human gene encoding the adhesion molecule CD2 (CD2) (Supplementary Fig. 1) , as well as Zfp36l1 fl/fl CD2-iCre + and Zfp36l2 fl/ fl CD2-iCre + mice 24 ; in these mice, each RBP gene is deleted early in lymphoid ontogeny. CD21 hi CD23 − MZ B cells were ninefold less abundant in Zfp36l1 fl/fl CD2-iCre + mice than in Zfp36l1 fl/fl CD2-iCre − mice but were normal in abundance in Zfp36 fl/fl CD2-iCre + and Zfp36l2 fl/fl CD2-iCre + mice (Fig. 1a) . The number of CD21 + CD23 + Fo B cells was slightly lower in Zfp36l1 fl/fl CD2-iCre + mice than in Zfp36l1 fl/fl CD2-iCre − mice ( Fig. 1b) . Transcripts encoding the family members ZFP36, ZFP36L1 and ZFP36L2 were expressed in MZ B cells from C57BL/6 mice ( Fig. 1c) , which indicated that the specific requirement for ZFP36L1 was not due to cell-specific mRNA expression. Thus, ZFP36L1 was required for the development or maintenance of MZ B cells, and its absence was not compensated for by ZFP36 or ZFP36L2.
B cell-intrinsic requirement for ZFP36L1
When Zfp36l1 was deleted at the pro-B cell stage in Zfp36l1 fl/fl Mb1 Cre/+ mice (in which Zfp36l1 is deleted by Cre, expressed from a Cre-encoding gene knocked into the gene encoding the immunoglobulin α-chain signaling subunit Mb1 (CD79A)), these mice also showed a loss of MZ B cells relative to the abundance of these cells in their Zfp36l1 fl/fl Mb1 +/+ littermates (data not shown). Zfp36l1 fl/fl Cd23-Cre + mice, in which Zfp36l1 is deleted at the transitional 2 (T2) B cell stage (by Cre expressed from a transgene derived from the gene encoding the low-affinity IgE receptor CD23) 26 , also had tenfold fewer MZ B cells and twofold fewer CD93 + B220 + IgM hi CD21 hi MZP B cells than did their Zfp36l1 fl/fl Cd23-Cre − littermates ( Fig. 2a,b ). We observed a small but significant fourfold decrease in B220 int CD19 + B-1 cells in the peritoneal cavity of Zfp36l1 fl/fl Mb1 Cre/+ mice relative to their abundance in Zfp36l1 fl/fl Mb1 +/+ mice, with both CD5 + B-1a cells and CD5 − B-1b cells affected ( Supplementary Fig. 2a-d) .
In contrast, the number of B220 + CD19 lo B2 cells in the peritoneal cavity of Zfp36l1 fl/fl Mb1 Cre/+ mice was not different from that in Zfp36l1 fl/fl Mb1 +/+ mice ( Supplementary Fig. 2a,b) . In contrast to the much larger effect of the deletion of ZFP36L1 on the number of MZ B cells, these observations suggested only a minor role for ZFP36L1 in B-1 cells.
To further understand the role of ZFP36L1 in mature B cells, we used CD23-Cre to express a fusion protein of green fluorescent protein (GFP) and ZFP36L1 (GFP-ZFP36L1) from the Rosa26 locus (R26 GFPZFP36L1 ) 25 . In R26 GFPZFP36L1 Cd23-Cre + mice, GFP-ZFP36L1 expression was observed from the T2 B cell stage ( Supplementary Fig. 2e ). The number of MZ B cells was 1.5-fold higher in R26 GFPZFP36L1 Cd23-Cre + mice than in R26 GFPZFP36L1 Cd23-Cre − mice, but there were no effects on Fo B cells or MZP B cells ( Fig. 2c,d) . Immunofluorescence staining of spleen sections with antibodies to identify MZ B cells indicated that the MZ was fivefold smaller in Zfp36l1 fl/fl Cd23-Cre + mice and expanded by 1.5 fold in R26 GFPZFP36L1 Cd23-Cre + mice relative to its size in Cre − control mice ( Fig. 2e,f) . This demonstrated a requirement for ZFP36L1 from the T2 B cell stage for the development and/or maintenance of MZ B cells.
Maintenance of MZ and MZP B cells requires ZFP36L1
To investigate the continued requirement for ZFP36L1 in MZ B cells, we used a transgene encoding a fusion of Cre and the tamoxifen-inducible estrogen receptor variant ERT2, targeted to the mouse Rosa26 locus (R26 ERT2−Cre ). In this context, Cre activity is induced following the administration of tamoxifen to mice. In Zfp36l1 fl/fl R26 ERT2−Cre/+ mice, 7 d of tamoxifen treatment by oral gavage induced the recombination and deletion of Zfp36l1 in B cells and a 1.3-fold decrease in the number of MZ B cells relative to the number of these cells in Zfp36l1 +/+ R26 ERT2−Cre/+ mice ( Supplementary Fig. 3a,b) . The recombination efficiency of Zfp36l1 remained high at later time points, and MZ B cells decreased 1.7-fold by day 10 and 3.2-fold by day 14 of tamoxifen treatment in Zfp36l1 fl/fl R26 ERT2−Cre/+ mice relative to their abundance in Zfp36l1 +/+ R26 ERT2−Cre/+ mice ( Supplementary Fig. 3c-f ). This ongoing depletion of MZ B cells was selective, as the number of Fo B cells was not lower at any of the three time points assessed ( Supplementary  Fig. 3b,d,f) . To exclude the possibility of an effect of the deletion of Zfp36l1 in non-hematopoietic cells in Zfp36l1 fl/fl R26 ERT2−Cre/+ mice 27, 28 , we reconstituted lethally irradiated CD45.1 + B6.SJL mice with bone marrow from CD45.2 + Zfp36l1 fl/fl R26 ERT2−Cre/+ or CD45.2 + Zfp36l1 +/ + R26 ERT2−Cre/+ mice and, 8 weeks after reconstitution, administered tamoxifen to the host mice by oral gavage. At 7 d following tamoxifen treatment, purified B cells from Zfp36l1 fl/fl R26 ERT2−Cre/+ showed more than 80% deletion of Zfp36l1 (Fig. 3a) . Chimeric mice reconstituted with Zfp36l1 fl/fl R26 ERT2−Cre/+ bone marrow had a selective loss of MZ and MZP B cells at 7 d after tamoxifen treatment (Fig. 3b) , while the Fo and transitional B cell subsets remained unchanged in number relative to that in the chimeras reconstituted with Zfp36l1 +/+ R26 ERT2−Cre/+ bone marrow ( Fig. 3b and data not shown). Therefore, ZFP36L1 was dispensable for the maintenance of Fo B cells but was necessary for the persistence of MZ and MZP B cells.
To address whether ZFP36L1 affects B cell survival, we used flow cytometry to measure the presence of active caspase-3. There was a 2.5-fold greater proportion of MZ B cells positive for active caspase-3 in chimeras reconstituted with Zfp36l1 fl/fl R26 ERT2−Cre/+ bone marrow than in those reconstituted with Zfp36l1 +/+ R26 ERT2−Cre/+ bone 
Cd23-Cre A r t i c l e s marrow ( Fig. 3c) . In contrast, there was no greater proportion of Fo B cells positive for active caspase-3 in chimeras reconstituted with Zfp36l1 fl/fl R26 ERT2−Cre/+ bone marrow than in chimeras reconstituted with Zfp36l1 +/+ R26 ERT2−Cre/+ bone marrow ( Fig. 3c) . Furthermore, the proportion of cells positive for active caspase-3 was similarly greater among MZ B cells (but not Fo B cells) from Zfp36l1 fl/fl Mb1 Cre/+ mice than among those from Zfp36l1 fl/fl Mb1 +/+ mice ( Fig. 3d) .
We assessed the turnover of MZ B cells in Zfp36l1 fl/fl Mb1 Cre/+ mice by measuring labeling with the thymidine analog BrdU following its administration for 14 d in the drinking water. BrdU is incorporated into highly proliferative pre-B cells in the bone marrow but not into non-proliferative transitional or naive B cell subsets, including MZ B cells 29 . At day 14, 50% of MZ B cells were BrdU + in Zfp36l1 fl/fl Mb1 Cre/+ mice, but only 30% of MZ B cells were BrdU + in Zfp36l1 fl/fl Mb1 +/+ mice (Fig. 3e) . Approximately 17% of Fo B cells were BrdU + in both Zfp36l1 fl/fl Mb1 Cre/+ mice and Zfp36l1 fl/fl Mb1 +/+ mice (Supplementary Fig. 4a ). There were slightly fewer BrdU + T2 and MZP B cells in Zfp36l1 fl/fl Mb1 Cre/+ mice than in Zfp36l1 fl/fl Mb1 +/+ mice (Supplementary Fig. 4a ). In contrast, BrdU incorporation was 1.5-fold lower in MZ B cells and slightly greater in the T2 B cells of in R26 GFPZFP36L1 Cd23-Cre + mice than in those of R26 GFPZFP36L1 Cd23-Cre − mice ( Fig. 3f and Supplementary Fig. 4b ). These data indicated that ZFP36L1 was not required for the survival of Fo B cells but was essential for the survival of MZ B cells.
Gene-expression changes after inducible deletion of Zfp36l1
ZFP36L1 controls gene expression by promoting RNA decay 23, 25 . To identify direct targets of ZFP36L1, we performed RNA-based next-generation sequencing (RNA-seq) of sorted MZ B cells from tamoxifen-treated Zfp36l1 fl/fl R26 ERT2−Cre/+ and Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre mice. We observed a significantly lower number of reads mapped within the loxPflanked region of Zfp36l1 in MZ B cells from Zfp36l1 fl/fl R26 ERT2−Cre/+ than in that region in such cells from Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre mice ( Supplementary Fig. 5a ), which indicated effective deletion of Zfp36l1. After loss of Zfp36l1, we observed a significantly higher expression of 330 transcripts and lower expression of 215 transcripts in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells. Of those, the expression of 84 transcripts and 26 transcripts was increased or decreased, respectively, by more than 1.5-fold ( Fig. 4a,b and Supplementary Tables 1-3) . We also observed an increase in the expression of Zfp36l2 after deletion of Zfp36l1 ( Fig. 4a; Supplementary  Fig. 5b ), which suggested that ZFP36L2 did not fully functionally compensate for ZFP36L1 in MZ B cells.
iCLIP can identify the direct targets of RBPs and the specific nucleotide contacts between RBPs and RNA, but this method requires a large numbers of cells and is not sensitive enough to apply to the small number of MZ B cells available. Therefore, we used iCLIP data for ZFP36L1 in activated Fo B cells 25 to identify candidate mRNAs that can be bound by ZFP36L1. 73 genes with higher expression in Zfp36l1 fl/ fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells, 11 of which showed a change in expression of over 1.5-fold, were identified by iCLIP as possible direct targets of ZFP36L1 ( Fig. 4b and Supplementary Tables 2 and 3 ). 24 transcripts with lower expression in in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells were also found in the iCLIP data for ZFP36L1; however, only one transcript, Per2 (which encodes the circadian protein mPer2), exhibited a change in expression of over 1.5-fold ( Fig. 4b and Supplementary Table 2 ), which suggested that 
the iCLIP data represented a stringent criterion for identifying direct targets of ZFP36L1 in MZ B cells.
To identify the functions of the products of the transcripts that were expressed differentially in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells relative to their expression in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells, we performed gene-set-enrichment analysis (GSEA) of all genes with significantly altered expression (adjusted P value, <0.01) ( Supplementary Tables 2 and 3 ). Because many of the genes expressed differentially were recurrent within distinct GSEA pathways, to prevent over-representation of redundant GO terms, we summarized our GSEA analysis using the software tool REVIGO to reduce and visualize gene ontology. This analysis indicated that many of the differentially expressed transcripts encoded products involved in signaling, cellular adhesion and migration, cell cycle and proliferation, and programmed cell death ( Fig. 4c) . Transcripts with lower expression did not encode products that constitute any common pathway or gene set, which suggested that these transcripts did not have a common function in MZ B cells.
The ZFP36 family of RBPs has been shown to promote cell quiescence 25, 30 . The expression of Ccna2 mRNA (which encodes cyclin A2), Cdc6 mRNA (which encodes the cell-division protein CDC18L), Pim1 mRNA (which encodes the serine-threonine kinase PIM1), and Cdk1 mRNA (which encodes the cyclin-dependent kinase Cdc2) was ≥1.5 fold higher in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre/+ MZ B cells (Supplementary Tables 1 and 2) . To assess the consequences of that, we analyzed the proportion of MZ B cells in Zfp36l1-deficient mice expressing the cyclin-dependent kinase inhibitor p27 KIP1 (encoded by Cdkn1b), a marker of cell quiescence. The expression of p27 in MZ B cells and the proportion of p27 + MZ B cells isolated from tamoxifen-treated Zfp36l1 fl/fl R26 ERT2−Cre/+ mice was similar to that in Zfp36l1 +/+ R26 ERT2−Cre/+ mice ( Supplementary  Fig. 6a-c) . The expression of p27 was unchanged in MZ B cells from Zfp36l1 fl/fl Mb1 Cre/+ mice relative to its expression in such cells from Zfp36l1 fl/fl Mb1 +/+ mice (Supplementary Fig. 6a-c) . Furthermore, the frequency of MZ B cells that stained positive for the proliferation marker Ki67 in Zfp36l1 fl/fl Mb1 Cre/+ mice was not different the staining of such cells in MZ B cells from Zfp36l1 fl/fl Mb1 +/+ mice, and the proportion of MZ and Fo B cells that stained with the DNA-binding dye DAPI was also unchanged in these mice ( Supplementary  Fig. 6d-g) . Together these data suggested that the reduction in the number of MZ B cells after developmentally programmed or induced deletion of Zfp36l1 was not due to loss of quiescence.
ZFP36L1 enforces MZ B cell identity
To further understand the changes in the MZ B cell transcriptome that arose from deletion of Zfp36l1, we compared transcripts that were expressed differentially in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells relative to their expression in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells with transcripts that were expressed differentially in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre (wild-type) MZ B cells relative to their expression in Zfp36l1 fl/fl (wild-type) Fo B cells. 72% (54) of the transcripts with the greatest increase in expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells relative to that in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells had higher expression in wild-type Fo B cells than in wild-type MZ B cells ( Fig. 5a and Supplementary Table 4) . Only a subset of the transcripts for which Fo B cells showed enrichment (relative to their abundance in MZ B cells) were increased in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells (Fig. 5a) , which indicated that the sorted Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells were not contaminated with Zfp36l1 fl/fl R26 ERT2−Cre/+ Fo B cells. Some transcripts that had higher expression in MZ B cells than in Fo B cells in wild-type mice, such as Plxnd1 (which encodes plexin D1) and Myc (which encodes the cell-cycle regulator c-Myc), also had higher expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells (Supplementary Table 4) . Thus, the MZ B cells that remained in Zfp36l1 fl/fl R26 ERT2−Cre/+ mice after treatment with tamoxifen had higher expression of transcripts associated with a Fo B cell phenotype.
To determine the effect of GFP-ZFP36L1 on the transcriptome of Fo B cells, we used RNA-seq analysis to compare the transcriptome of Fo B cells sorted from R26 GFPZFP36L1 Cd23-Cre + mice with that of Fo B cells from R26 GFPZFP36L1 Cd23-Cre − mice. Pairwise A r t i c l e s comparison with genes expressed differentially by wild-type Fo B cells relative to their expression by MZ B cells indicated that the Fo B cells from R26 GFPZFP36L1 Cd23-Cre + mice showed a trend toward higher expression of genes 'preferentially' expressed by MZ B cells and lower expression of genes characteristically expressed by Fo B cells ( Fig. 5b and Supplementary Table 5) . A negative correlation was evident for genes expressed differentially by Fo B cells from R26 GFPZFP36L1 Cd23-Cre + mice relative to their expression in Fo B cells from R26 GFPZFP36L1 Cd23-Cre − mice and genes expressed differentially by Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells relative to their expression in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells ( Fig. 5c and Supplementary Table 6 ), which suggested that ZFP36L1 was needed to maintain the identity of MZ B cells. We next assessed cell-surface markers expressed by Fo B cells from R26 GFPZFP36L1 Cd23-Cre + mice. GFP + Fo B cells from those mice had higher expression of CD21, CD1d and major histocompatibility complex class II than that of Fo B cells from R26 GFPZFP36L1 Cd23-Cre − mice (Fig. 5d) , indicative of a phenotype and 'activation' status that resembled that of MZ B cells. Furthermore, staining of spleen sections with fluorescent antibodies showed a greater abundance of CD1d + cells that also expressed IgD within the follicles of R26 GFPZFP36L1 Cd23-Cre + mice than in those of R26 GFPZFP36L1 Cd23-Cre − mice ( Fig. 2f and  Supplementary Fig. 7a) . A r t i c l e s that observed in Fo B cells from those mice ( Fig. 5e ). Calcium flux elicited by cross-linkage of the BCR in CD93 + transitional B cell subsets (data not shown) or CD21 + CD23 + Fo B cells (Fig. 5e) from Zfp36l1 fl/fl Mb1 Cre/+ mice was not different from that elicited in the same subsets from Zfp36l1 fl/fl Mb1 +/+ mice. Incubation of cells with EGTA chelates extracellular calcium and limits BCR-stimulated calcium flux to that released from internal stores. Stimulation with antibody to IgM (anti-IgM) elicited less calcium release in EGTA-treated MZ B cells from Zfp36l1 fl/fl Mb1 Cre/+ mice than in those from Zfp36l1 fl/fl Mb1 +/+ mice (Fig. 5e) . This indicated defective release of calcium from the internal stores of Zfp36l1 fl/fl Mb1 Cre/+ MZ B cells. Thus, ZFP36L1 enhanced BCR signaling in MZ B cells.
To investigate the function of the MZ B cells in the ZFP36L1-deficient mice that remained after deletion of Zfp36l1, we immunized Zfp36l1 fl/ fl Cd23-Cre + and R26 GFPZFP36L1 Cd23-Cre + mice, as well as their control littermates (Zfp36l1 fl/fl Cd23-Cre − and R26 GFPZFP36L1 Cd23-Cre − , respectively), with the CD1d-restricted antigen NP-α-GalCer 32 . At 4 d after immunization, the titer of NP-specific IgM in serum was similar in Zfp36l1 fl/fl Cd23-Cre + mice and Zfp36l1 fl/fl Cd23-Cre − mice (Supplementary Fig. 7b) , which indicated that the number of MZ B cells in ZFP36L1-deficient mice was not limiting the antibody response to antigen in vivo. These data suggested that ZFP36L1 did not have a role in the MZ B cell response to CD1d-restricted humoral responses in vivo but enforced the MZ B cell phenotype in mice.
ZFP36L1 targets IRF8 and KLF2 to enforce MZ B cell identity
Loss of IRF8 leads to an enlarged MZ B cell compartment 13 , suggestive of a role for IRF8 in limiting the number of MZ B cells. The expression of Irf8 mRNA was 1.3-fold higher in MZ B cells from Zfp36l1 fl/fl R26 ERT2−Cre/+ than in those from Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre mice ( Fig. 6a) and was lower in in Fo B cells from R26 GFPZFP36L1 Cd23-Cre + mice than in those from R26 GFPZFP36L1 Cd23-Cre-mice (Fig. 6b) . The expression of IRF8 protein was also higher in MZ B cells from Zfp36l1 fl/fl Mb1 Cre/+ than in those from Zfp36l1 fl/fl Mb1 +/+ mice (Fig. 6c,d) .
Irf8 mRNA contains a highly conserved AU-rich element in its 3′ UTR and was bound by ZFP36L1 in our iCLIP analysis of activated B cells (Fig. 6e) , which indicated it was probably a direct target of ZFP36L1 in MZ B cells.
To determine whether genes that are targets of IRF8 contributed to the loss of MZ B cells in the absence of ZFP36L1, we sought to determine whether transcripts that were expressed differentially by Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells relative to their expression in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells were identified as targets of IRF8 in high-quality data obtained by chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) 33 . We found that a subset of the transcripts for which wild-type Fo B cells showed enrichment relative to their abundance in wild-type MZ B cells and that had higher expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells were bound by IRF8 (Fig. 6f) . 
A r t i c l e s
This suggested that higher expression of IRF8 contributed directly to the altered expression of these genes in the absence of ZFP36L1. Furthermore, the distribution of direct ZFP36L1 targets identified by iCLIP analysis showed minimal overlap with IRF8 targets (Fig. 6f,g) . This indicated that ZFP36L1 and IRF8 generally acted in a hierarchical manner whereby ZFP36L1 targeted a range of transcripts, including the RNA encoding IRF8, which in turn targeted genes encoding products important for cell survival, localization, signaling and the maintenance of MZ B cell identity. The expression of Klf2 mRNA was 3.1-fold higher in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells (Fig. 7a) . The expression of KLF2 protein was also higher, as assessed by flow cytometry, in Zfp36l1 fl/fl Mb1 Cre/+ MZ B cells than in Zfp36l1 fl/fl Mb1 +/+ MZ B cells (Fig. 7b) and also in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/+ MZ B cells (Fig. 7c) . Klf2 mRNA contains a TATTTATT AU-rich element in its 3′ UTR that is conserved among mammalian species that have an ortholog of this mRNA (Fig. 7d) . iCLIP analysis indicated that ZFP36L1 bound in this AU-rich element (Fig. 7d) ; however, the data did not reach statistical significance due to the low abundance of Klf2 mRNA in activated B cells 15, 34 . Thus, ZFP36L1 might directly limit expression of KLF2.
To determine if KLF2 contributed to the altered gene-expression profile of Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells, we used ChIP-seq data for KLF2 (ref. 35 ) and microarray analysis of transcripts expressed differentially by Klf2 fl/fl Cd19-Cre + B cells relative to their expression by wild-type B cells 14 to generate a list of candidate targets of KLF2 relevant to B cells. This list identified a set of genes that were bound by KLF2 and had higher expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre MZ B cells and higher expression in wild-type Fo B cells than in wild-type MZ B cells (Fig. 7e) . Furthermore, this analysis showed that among the transcripts with higher expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells, the KLF2bound genes were generally absent from both the iCLIP data set for ZFP36L1 and the ChIP-seq data set for IRF8 ( Fig. 7f) , which indicated that the overexpression of KLF2 in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells was consequential for the transcriptome. Together these analyses suggested a model whereby ZFP36L1 limits the expression of a few genes, including those encoding the transcription factors IRF8 and KLF2, which in turn regulate genes important for the identity and survival of MZ B cells (Supplementary Fig. 7c) .
ZFP36L1 regulates B cell localization
GSEA of 116 transcripts that had both higher expression in Zfp36l1 fl/ fl R26 ERT2−Cre/+ MZ B cells than in Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre cells and lower expression in Fo B cells from R26 GFPZFP36L1 Cd23-Cre + mice than in those from R26 GFPZFP36L1 Cd23-Cre − mice (Supplementary Fig. 8a ) identified pathways involved in B cell trafficking (Supplementary Fig. 8b) . Flow cytometry indicated higher expression of the adhesion molecule CD62L and the integrin β 7 , but no difference in the expression of the C-type lectin CD69 (a surrogate marker for the receptor S1PR1), on the surface of B cells from R26 GFPZFP36L1 Cd23-Cre + mice than on such cells from R26 GFPZFP36L1 Cd23-Cre − mice (Fig. 8a) . We observed little if any difference in expression of the chemokine receptors CXCR4 and CXCR5, the integrins β 1 and LFA-1 (α L β 2 ) on the surface of MZ and Fo B cells from Zfp36l1 fl/fl Mb1 Cre/+ mice relative to that on such cells from Zfp36l1 fl/fl Mb1 +/+ mice (data not shown). The expression of mRNA encoding S1PR1 in MZ B cells from Zfp36l1 fl/fl R26 ERT2−Cre/+ was also not different from that in MZ B cells from Zfp36l1 +/+ R26 ERT2−Cre/ERT2−Cre mice (Supplementary Fig. 8c ). To assess whether ZFP36L1 affected the localization of MZ B cells, we measured by flow cytometry the binding of phycoerythrin-conjugated anti-CD19 to MZ B cells, following intravenous administration to mice. The binding of this antibody to MZ B cells from Zfp36l1 fl/fl Cd23-Cre + mice was 1.5-fold lower than its binding to MZ B cells from Zfp36l1 fl/fl Cd23-Cre − mice (Fig. 8b) , which indicated that ZFP36L1 promoted localization to the MZ. We generated mixed-bone-marrow chimeras by reconstituting lethally irradiated B6.SJL mice with bone marrow from Zfp36l1 fl/fl R26 ERT2−Cre/+ or Zfp36l1 +/+ R26 ERT2−Cre/+ mice, together with bone marrow from µMT mice (which lack mature B cells); this resulted in 'Zfp36l1 fl/fl R26 ERT2−Cre/+ :µMT' chimeras and 'Zfp36l1 +/+ R26 ERT2−Cre/+ : µMT' chimeras. Following reconstitution, we administered tamoxifen to induce deletion of Zfp36l1 and measured the localization of CD1d + cells by antibody staining of splenic tissue sections. We observed a greater proportion of CD1d + B cells in the splenic follicles of Zfp36l1 fl/fl R26 ERT2−Cre/+ :µMT chimeras than in those of Zfp36l1 +/+ R26 ERT2−Cre/+ :µMT chimeras (Fig. 8c) . CD1d + B cells in the splenic follicles of Zfp36l1 fl/fl R26 ERT2−Cre/+ :µMT chimeras did not express IgD (Supplementary Fig. 7a ), which indicated that they were MZ B cells. We defined the boundaries of the splenic follicle by staining of MOMA-1, a marker specific for metallophilic macrophages (Supplementary Fig. 8e) , and quantified the mean fluorescent intensity (MFI) of CD1d within the follicle. The MFI of CD1d was greater in the splenic follicles of Zfp36l1 fl/fl R26 ERT2−Cre/+ :µMT chimeras than in those of Zfp36l1 +/+ R26 ERT2−Cre/+ :µMT chimeras (Fig. 8d) .
The MFI of CD1d in the MZ of Zfp36l1 fl/fl R26 ERT2−Cre/+ :µMT chimeras was not greater than that in the MZ of Zfp36l1 +/+ R26 ERT2−Cre/+ :µMT chimeras (Fig. 8d) , which indicated that the greater MFI of CD1d in A r t i c l e s the follicles of Zfp36l1 fl/fl R26 ERT2−Cre/+ :µMT chimeras did not result from an increase in CD1d expression on all B cells. Normalization of the MFI of CD1d within the splenic follicle to the MFI of CD1d within the Fo and MZ confirmed this result (Fig. 8d) . Thus, ZFP36L1 was required for the proper localization of MZ B cells.
DISCUSSION
Here we reported an essential role for ZFP36L1 in the maintenance of MZ B cells. ZFP36L1 mediated this role by interacting with and limiting the expression of a set of transcripts that promoted the Fo B cell phenotype. The relevant targets of ZFP36L1 in this context were distinct from previously identified targets of ZFP36L1 and included genes encoding the transcription factors IRF8 and KLF2 and regulators of adhesion and migration. This ability of ZFP36L1 to regulate different transcripts at discrete stages of development is reminiscent of transcription factors that control gene expression characteristic of a particular developmental stage 36 . Regulation by ZFP36L1 can be considered a post-transcriptional RNA operon or 'regulon' 37 that maintains the identity of MZ B cells. ZFP36L1-related proteins regulate cell fate in other developmental biology systems. In Caenorhabditis elegans, the germline and somatic cell fates are regulated by multiple RBPs, many of which contain tandem CCCH zinc fingers. Among those, OMA-1 (ref. 38) and POS-1 (ref. 39 ) bind with high affinity to AU-rich sequences in the 3′ UTR of mRNA. Systems analysis has indicated extensive crosstalk between RBPs and transcription factors in C. elegans 40 . Our findings have indicated the existence of similar networks in mammalian cells. Establishing this principle in additional mammalian systems will require the identification of both the relevant RBPs and the bound targets.
The specific requirement for ZFP36L1 in MZ B cells is in contrast to the redundant function of ZFP36L1 and ZFP36L2 in early lymphocyte development 25 . ZFP36L1 binds to Zfp36l2 mRNA, and the abundance of Zfp36l2 mRNA was increased in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells, which suggested that ZFP36L1 suppressed its paralog in MZ B cells. It thus appears that ZFP36L2 was unable to compensate for the absence of ZFP36L1 in MZ B cells. This might reflect differences in the post-translational biology of the RBPs encoded, such as the effects of specific phosphorylation or of multi-protein complex formation. Alternatively, there may be differences among members of the ZFP36 family in their ability to bind to and regulate specific targets. Extensive further work will be needed to elucidate the molecular basis of the redundant and non-redundant functions of these RBPs.
We identified IRF8 and KLF2 as direct targets of ZFP36L1 that regulated many genes encoding products important for MZ B cell identity. The molecular basis for the regulation of the MZ B cell pool by KLF2 might also relate to its ability to control the expression of adhesion receptors, while the mechanisms by which IRF8 limits the size of the MZ B cell compartment is unclear 13, 41 . Many, but not all, of the indirect changes in the transcriptome of Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells appeared to stem from their higher expression of IRF8 or KLF2, as these transcription factors accounted for 18 of 54 differentially expressed 'signature' genes of Fo B cells. Many targets of KLF2 that were not targets of ZFP36L1 had higher expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells, and many of these were also suppressed in Fo B cells from R26 GFPZFP36L1 Cd23-Cre + mice. Thus, the transcriptome of MZ B cells was regulated by a network of factors that acted transcriptionally and post-transcriptionally, in which ZFP36L1 was a major hub. Additional targets of ZFP36L1 identified by iCLIP analysis with higher expression in Zfp36l1 fl/fl R26 ERT2−Cre/+ MZ B cells encoded products that might contribute to the abnormal localization and survival of MZ B cells. The following have all been linked to adhesion and metastasis: PIM1, which is a kinase 42, 43 ; KIAA0101 (2810417H13Rik), a factor associated with proliferating cell nuclear antigen 44 ; Myadm ('myeloid-associated differentiation marker'), a putative adaptor of uncertain function 45, 46 ; Txnrd1 ('thioredoxin reductase 1'), an enzyme that catalyzes the reduction of thioredoxin 47, 48 ; and Bhlhe40, a transcriptional regulator 49 . ZFP36L1 might act to promote the interaction between MZ B cells and the unique extracellular matrix components for which the MZ is enriched and might have an important role in promoting the survival of MZ B cells 3 . Such mechanisms protect MZ B cells from apoptosis. We are therefore tempted to speculate that ZFP36L1-deficient MZ B cells lack such pro-survival signals when access to the MZ is limited. This might be analogous to the process of anoikis, whereby detachment of adherent cells from a niche can lead to programmed cell death 50 . In summary, our data suggest that ZFP36L1 acts post-transcriptionally to enforce the phenotype of MZ B cells and that in its absence, MZ B cells are mislocalized and die. It will be important for future studies to establish whether these mechanisms contribute to pathology in lymphoma or autoimmune disease.
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